However, when considering all events reported by investigators (independently of the Clinical Endpoint Committee adjudication status), the difference between these groups did not reach statistical significance at 0.025 level.
← all excerpts
Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives.
1
—
—